project id: TCGA-BRCA; case submitter id: TCGA-BH-A0HF; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.7; spectrophotometer method: UV Spec; age at index: 77; days to birth: -28233; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1931; age at diagnosis: 28233; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage IA; ajcc pathologic t: T1c; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 727.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 549; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-BH-A0HF-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent stromal cells: 55.0;